Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Sales (2016 - 2025)

cbdMD's Return on Sales history spans 10 years, with the latest figure at 0.06% for Q4 2025.

  • For Q4 2025, Return on Sales fell 6.0% year-over-year to 0.06%; the TTM value through Dec 2025 reached 0.12%, up 6.0%, while the annual FY2025 figure was 0.11%, 8.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.06% at cbdMD, up from 0.14% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.14% in Q2 2021 and bottomed at 3.57% in Q2 2022.
  • The 5-year median for Return on Sales is 0.21% (2023), against an average of 0.67%.
  • The largest annual shift saw Return on Sales plummeted -370bps in 2022 before it skyrocketed 328bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 1.94% in 2021, then skyrocketed by 67bps to 0.63% in 2022, then surged by 69bps to 0.2% in 2023, then surged by 101bps to 0.0% in 2024, then plummeted by -2012bps to 0.06% in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Return on Sales are 0.06% (Q4 2025), 0.14% (Q3 2025), and 0.19% (Q2 2025).